5Staessen JA, Li Y, Thijs L, et al. Blood pressure reduction and cardi- ovascular prevention: an update including the 2003 - 2004 secondary prevention trials [ J]. Hypertension Res, 2005, 28 (5) : 385 - 407.
6Banegas JR, Segura J, Sobrino J, et aI. Spanish society of hyperten- sion ambulatory blood pressure monitoring registry investigators. Effec- tiveness of blood pressure control outside the medical setting [J]. Jour- nal of Hypertension, 2007, 49 ( 1 ) : 62 - 68.
7Hiall WR, Hoag S, Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study [J]. Circulation, 1995, 91 (5): 1472-1479.
8Criqui MH. Systemic atherosclerosis risk and the mandate for interven- tion in atherosclerotic peripheral arterial disease [ J 2- Am ] Cardio, 2001, 88 (7B): 43J-47J.
9Liang KM, Sheu WH, Lee WL, et al. Decreased circulating protective adiponectin level is associated [J]. Int J Cardio, 2008, 129 ( 1 ) : 76 -78.
